These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1428733)

  • 1. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
    Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
    Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
    Weiss M; Maslak P; Feldman E; Berman E; Bertino J; Gee T; Megherian L; Seiter K; Scheinberg D; Golde D
    J Clin Oncol; 1996 Sep; 14(9):2480-5. PubMed ID: 8823326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
    Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
    Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
    Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
    Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vindesine in the treatment of leukaemia.
    Gökbuget N; Hoelzer D
    Leuk Lymphoma; 1997 Aug; 26(5-6):497-506. PubMed ID: 9389357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
    Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
    Bajorin D; Kelsen DP
    Cancer Invest; 1990; 8(2):135-41. PubMed ID: 1698110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Freund M; Diedrich H; Ganser A; Gramatzki M; Heil G; Heyll A; Henke M; Hiddemann W; Haas R; Kuse R
    Cancer; 1992 Feb; 69(3):709-16. PubMed ID: 1730121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
    Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.